Parameters | Data |
---|---|
Male, n (%) | 25 (86.2%) |
Mean age, years | 59.2 ± 11.3 |
Lesion types | |
Right liver | 16 (55.2%) |
Left liver | 2 (6.9%) |
Whole liver | 11 (37.9%) |
Median duration of symptom, months | 1.0 (0.6, 6.0) |
Recurrent/unresectable HCC | 4 (13.8%)/25 (86.2%) |
Systemic chemotherapy | 1 (3.4%) |
Targeted therapy | 13 (44.8%) |
Etiology HBV/HCV | 25 (86.2%)/2 (6.9%) |
BCLC stage B/C | 7 (24.1%)/22 (75.9%) |
Child–Pugh class A/B | 22 (75.9%)/7 (24.1%) |
One/two/multiple tumors | 15 (51.7%)/4 (13.8%)/10 (34.5%) |
Portal venous tumor emboli | 9 (31.0%) |
Local or distant metastasis | 14 (48.3%)/3 (10.3%) |
Tumor diameter, mm | 91.6 ± 41.2 |